Skip to main content
Elliot Androphy, MD, Dermatology, Indianapolis, IN

ElliotJAndrophyMD

Dermatology • Indianapolis, IN

Kampen-Norins Professor and Chair

Join to view full profile

Dr. Androphy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Androphy's full profile

Already have an account?

  • Office

    550 University Blvd
    Ste 3240
    Indianapolis, IN 46202
    Phone+1 317-944-7744
    Fax+1 317-944-7051

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Dermatology, 1982 - 1986
  • UPMC Medical Education
    UPMC Medical EducationResidency, Dermatology, 1980 - 1982
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1979

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2010 - 2025
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Fellow American Academy of Microbiology, 2022
  • Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Press Mentions

  • Kovina Therapeutics Receives National Cancer Institute Grant to Advance Human Papillomavirus Cancer Treatment
    Kovina Therapeutics Receives National Cancer Institute Grant to Advance Human Papillomavirus Cancer TreatmentJune 27th, 2022
  • Grant Announcement: Cure SMA Awards $150,000 Grant to Timra Gilson, Ph.D., Indiana University
    Grant Announcement: Cure SMA Awards $150,000 Grant to Timra Gilson, Ph.D., Indiana UniversityMarch 5th, 2020

Grant Support

  • Functions Of Papillomavirus E6National Cancer Institute2010–2012
  • Small Molecule Inhibitors Of Oncogenic Human PapillomavirusNational Cancer Institute2011
  • Control Of Papillomavirus Expression And TransformationNational Cancer Institute2010–2011
  • Cooperative LEAD Development Program For Treatment Of Spinal Muscular AtrophyEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
  • Testing Compounds That Increase SMN Levels For Efficacy In Mouse Models Of SMANational Institute Of Neurological Disorders And Stroke2010
  • Functions Of Papillomavirus E6National Cancer Institute2010
  • Small Molecule Inhibitors Of Oncogenic Human PapillomavirusNational Cancer Institute2008–2010
  • Testing Compounds That Increase SMN Levels For Efficacy In Mouse Models Of SMANational Institute Of Neurological Disorders And Stroke2009
  • Optimization Of Drug-Like Compounds For Treatment Of Spinal Muscular AtrophyEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2009
  • Control Of Papillomavirus Expression And TransformationNational Cancer Institute2002–2009
  • High Throughput Screen For SMANational Institute Of Mental Health2008
  • Functions Of Human Papillomavirus E6National Cancer Institute2004–2008
  • High Throughput Screen For Compounds To Treat Papillomavirus Induced CancersNational Cancer Institute2006–2007
  • Papillomavirus Inhibitors For Aids-Related MalignanciesNational Cancer Institute2002–2005
  • Molecular Pathogenesis Of Spinal Muscular AtrophyNational Institute Of Neurological Disorders And Stroke2001–2004
  • Functions Of The Human Papillomavirus E6 OncoproteinNational Cancer Institute2001
  • Molecular Pathogenesis Of Spinal Muscular AtrophyNational Institute Of Neurological Disorders And Stroke2000–2001
  • Core--Aids Related MalignancyNational Institute Of Allergy And Infectious Diseases1998–2001
  • Functions Of The Human Papillomavirus E6 OncoproteinNational Cancer Institute1997–2001
  • Control Of Papillomavirus Expression And TransformatioNational Cancer Institute2000
  • Control Of Papillomavirus Expression And TransformationNational Cancer Institute1993–1999
  • Design Of Human Papillomavirus InhibitorsNational Institute Of Allergy And Infectious Diseases1995–1998
  • Papillomavirus E6 ProteinsNational Cancer Institute1994
  • Characterization Of Papillomavirus E6 ProteinsNational Cancer Institute1987–1993

Professional Memberships

Dr. Elliot Androphy, Dr. Elliot Androphy, MD, Dr. E Androphy, Dr. Elliot J Androphy